ONO-1110 / Ono Pharmaceutical - LARVOL DELTA

ONO-1110-04: A Study of ONO-1110 in Patients With Postherpetic Neuralgia (clinicaltrials.gov) - P2 | N=142 | Completed | Sponsor: Ono Pharmaceutical Co., Ltd. | Active, not recruiting ➔ Completed | Trial completion date: Aug 2026 ➔ May 2026

Trial completion • Trial completion date • Neuralgia

A Study of ONO-1110 in Patients With Major Depressive Disorder (clinicaltrials.gov) - P2 | N=103 | Completed | Sponsor: Ono Pharmaceutical Co., Ltd. | Active, not recruiting ➔ Completed | Trial completion date: Aug 2026 ➔ Apr 2026 | Trial primary completion date: Aug 2026 ➔ Apr 2026

Trial completion • Trial completion date • Trial primary completion date • CNS Disorders • Depression • Major Depressive Disorder • Mood Disorders • Psychiatry

A Study of ONO-1110 in Patients With Social Anxiety Disorder (clinicaltrials.gov) - P2 | N=115 | Completed | Sponsor: Ono Pharmaceutical Co., Ltd. | Active, not recruiting ➔ Completed | Trial completion date: Oct 2026 ➔ May 2026 | Trial primary completion date: Oct 2026 ➔ May 2026

Trial completion • Trial completion date • Trial primary completion date • CNS Disorders • Mood Disorders • Psychiatry • Social Anxiety Disorder

A Clinical Study of ONO-1110 in Patients With Fibromyalgia (clinicaltrials.gov) - P2 | N=175 | Completed | Sponsor: Ono Pharmaceutical Co., Ltd. | Active, not recruiting ➔ Completed | Trial completion date: Sep 2026 ➔ May 2026

Trial completion • Trial completion date • Fibromyalgia • Musculoskeletal Pain • Rheumatology

A Clinical Study of ONO-1110 in Patients With Hunner Type Interstitial Cystitis (clinicaltrials.gov) - P2 | N=57 | Completed | Sponsor: Ono Pharmaceutical Co., Ltd. | Active, not recruiting ➔ Completed | Trial completion date: Nov 2026 ➔ Jun 2026

Trial completion • Trial completion date • Interstitial Cystitis

A Clinical Study of ONO-1110 in Patients With Hunner Type Interstitial Cystitis (clinicaltrials.gov) - P2 | N=50 | Active, not recruiting | Sponsor: Ono Pharmaceutical Co. Ltd | Recruiting ➔ Active, not recruiting | Trial completion date: Aug 2026 ➔ Nov 2026 | Trial primary completion date: Jun 2026 ➔ Sep 2026

Enrollment closed • Trial completion date • Trial primary completion date • Interstitial Cystitis

A Clinical Study of ONO-1110 in Patients With Fibromyalgia (clinicaltrials.gov) - P2 | N=160 | Active, not recruiting | Sponsor: Ono Pharmaceutical Co. Ltd | Recruiting ➔ Active, not recruiting

Enrollment closed • Fibromyalgia • Musculoskeletal Pain • Pain • Rheumatology

ONO-1110-04: A Study of ONO-1110 in Patients With Postherpetic Neuralgia (clinicaltrials.gov) - P2 | N=140 | Active, not recruiting | Sponsor: Ono Pharmaceutical Co. Ltd | Recruiting ➔ Active, not recruiting

Enrollment closed • Neuralgia • Pain

A Study of ONO-1110 in Patients With Social Anxiety Disorder (clinicaltrials.gov) - P2 | N=100 | Active, not recruiting | Sponsor: Ono Pharmaceutical Co. Ltd | Recruiting ➔ Active, not recruiting

Enrollment closed • CNS Disorders • Mood Disorders • Psychiatry • Social Anxiety Disorder

A Study of ONO-1110 in Patients With Major Depressive Disorder (clinicaltrials.gov) - P2 | N=100 | Active, not recruiting | Sponsor: Ono Pharmaceutical Co. Ltd | Recruiting ➔ Active, not recruiting

Enrollment closed • CNS Disorders • Depression • Major Depressive Disorder • Mood Disorders • Psychiatry

A Study of ONO-1110 in Patients With Major Depressive Disorder (clinicaltrials.gov) - P2 | N=100 | Recruiting | Sponsor: Ono Pharmaceutical Co. Ltd | Not yet recruiting ➔ Recruiting

Enrollment open • CNS Disorders • Depression • Major Depressive Disorder • Mood Disorders • Psychiatry

A Study of ONO-1110 in Patients With Social Anxiety Disorder (clinicaltrials.gov) - P2 | N=100 | Recruiting | Sponsor: Ono Pharmaceutical Co. Ltd | Not yet recruiting ➔ Recruiting

Enrollment open • CNS Disorders • Mood Disorders • Psychiatry • Social Anxiety Disorder

A Study of ONO-1110 in Patients With Postherpetic Neuralgia (clinicaltrials.gov) - P2 | N=140 | Recruiting | Sponsor: Ono Pharmaceutical Co. Ltd | Not yet recruiting ➔ Recruiting

Enrollment open • Neuralgia • Pain

A Clinical Study of ONO-1110 in Patients With Fibromyalgia (clinicaltrials.gov) - P2 | N=160 | Recruiting | Sponsor: Ono Pharmaceutical Co. Ltd | Not yet recruiting ➔ Recruiting

Enrollment open • Fibromyalgia • Musculoskeletal Pain • Pain • Rheumatology

A Clinical Study of ONO-1110 in Patients With Hunner Type Interstitial Cystitis (clinicaltrials.gov) - P2 | N=50 | Recruiting | Sponsor: Ono Pharmaceutical Co. Ltd | Not yet recruiting ➔ Recruiting

Enrollment open • Interstitial Cystitis

A Study of ONO-1110 in Patients With Social Anxiety Disorder (clinicaltrials.gov) - P2 | N=100 | Not yet recruiting | Sponsor: Ono Pharmaceutical Co. Ltd

New P2 trial • CNS Disorders • Mood Disorders • Psychiatry • Social Anxiety Disorder

A Study of ONO-1110 in Patients With Major Depressive Disorder (clinicaltrials.gov) - P2 | N=100 | Not yet recruiting | Sponsor: Ono Pharmaceutical Co. Ltd

New P2 trial • CNS Disorders • Depression • Major Depressive Disorder • Mood Disorders • Psychiatry

A Clinical Study of ONO-1110 in Patients With Fibromyalgia (clinicaltrials.gov) - P2 | N=160 | Not yet recruiting | Sponsor: Ono Pharmaceutical Co. Ltd

New P2 trial • Fibromyalgia • Musculoskeletal Pain • Pain • Rheumatology

A Clinical Study of ONO-1110 in Patients With Hunner Type Interstitial Cystitis (clinicaltrials.gov) - P2 | N=50 | Not yet recruiting | Sponsor: Ono Pharmaceutical Co. Ltd

New P2 trial • Interstitial Cystitis

A Study of ONO-1110 in Patients With Postherpetic Neuralgia (clinicaltrials.gov) - P2 | N=140 | Not yet recruiting | Sponsor: Ono Pharmaceutical Co. Ltd

New P2 trial • Neuralgia • Pain